Small-incision lenticule extraction (SMILE) has shown great promise in the treatment of myopia; however, the literature is less extensive in its hyperopic counterpart. The purpose of this review is to detail the recent advancements and outcomes of SMILE in the treatment of hyperopic eye disease.
SMILE has demonstrated similar visual outcomes, regression rates, centration ability, safety profiles, and wound healing as hyperopic laser-assisted in situ keratomileusis (LASIK). Lenticule preservation and implantation show further promise in the correction of higher degrees of hyperopia.
Based on the current literature, SMILE represents a viable surgical alternative to LASIK in the correction of hyperopia. Lenticule intrastromal keratoplasty and small-incision lenticule intrastromal keratoplasty may be able to correct severe hyperopia in patients who would not otherwise be candidates for refractive surgery.
aDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City
bUtah Lions Eye Bank, Murray
cHoopes Durrie Rivera Research Center, Hoopes Vision, Draper, Utah
dMcGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas
eDepartment of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan Medical School, Ann Arbor, Michigan
fDepartment of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA
Correspondence to Majid Moshirfar, Medical Director, Hoopes Durrie Rivera Research Center, Hoopes Vision, 11820 S. State Street Suite #200, Draper, UT 84020, USA. Tel: +1 801 568 0200; fax: +1 801 563 0200; e-mail: firstname.lastname@example.org